FILE PHOTO: Vials of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are placed on a table for a photograph in a health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood/File Photo
FILE PHOTO: Vials of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weigh loss, are placed on a table for a photograph in a health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood/File Photo